Skip to main content

Research Repository

Advanced Search

Cardiotoxicity of breast cancer drug treatments

Haque, Maria; Atallah, Nehal; Patke, Rodhan; Harris, Anna E.; Woodcock, Corinne L.; Varun, Dhruvika; Thompson, Rachel L.; Jackson-Oxley, Jorja; Okui, Cyntholia H.; Dean, Alexander; Alsaleem, Mansour; Rakha, Emad; Irshad, Sheeba; Davis, Melissa B.; Jeyapalan, Jennie N.; Mongan, Nigel P.; Rutland, Catrin S.

Cardiotoxicity of breast cancer drug treatments Thumbnail


Authors

Maria Haque

Rodhan Patke

Dhruvika Varun

Rachel L. Thompson

Jorja Jackson-Oxley

Cyntholia H. Okui

Alexander Dean

Mansour Alsaleem

Sheeba Irshad

Melissa B. Davis



Abstract

Breast cancer (BC) is a leading cause of cancer-related mortality among women worldwide. BC is regarded as a systemic disease. Consequently, the majority of BC patients undergo systemic therapy to reduce the risk of distant metastasis (DM) and associated mortality. Although systemic therapies improve patients’ outcome, they are associated with significant side effects, particularly cardiotoxicity and cardiovascular complications. Such side effects vary significantly in severity and duration. Cardiotoxicity may remain undetected for years post-treatment until the symptoms of heart failure (HF) present in the patient, which can reduce life expectancy, quality of life, and even lead to death. Therefore, it is vital to investigate the cardiotoxic and cardiovascular risks of BC treatment regimens to identify patients who would benefit most from cardiac monitoring. As it stands, cardiotoxicity is reported from individual studies or for selected drug therapies only. This review fulfils a gap in the literature by combining clinical studies of cardiotoxicity together from clinical trial data published on clinicaltrials.gov.uk.

Citation

Haque, M., Atallah, N., Patke, R., Harris, A. E., Woodcock, C. L., Varun, D., Thompson, R. L., Jackson-Oxley, J., Okui, C. H., Dean, A., Alsaleem, M., Rakha, E., Irshad, S., Davis, M. B., Jeyapalan, J. N., Mongan, N. P., & Rutland, C. S. (2025). Cardiotoxicity of breast cancer drug treatments. Translational Oncology, 55, Article 102352. https://doi.org/10.1016/j.tranon.2025.102352

Journal Article Type Article
Acceptance Date Mar 4, 2025
Online Publication Date Mar 15, 2025
Publication Date 2025-05
Deposit Date Mar 24, 2025
Publicly Available Date Mar 25, 2025
Journal Translational Oncology
Electronic ISSN 1936-5233
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 55
Article Number 102352
DOI https://doi.org/10.1016/j.tranon.2025.102352
Public URL https://nottingham-repository.worktribe.com/output/46994628
Publisher URL https://www.sciencedirect.com/science/article/pii/S193652332500083X?via%3Dihub

Files





You might also like



Downloadable Citations